RxDoctor Payments Data

Blake Putman, MD

Family Medicine · Caro, MINPI 1659784338

Payments from drug & device makers

$2,063in general payments, 2019–2025

Across 135 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$409
  • AbbVie$373
  • Otsuka America Pharmaceutical, Inc.$249
  • AstraZeneca$179
  • GSK$155
  • Amgen$142
  • plus $556 from 18 others

What the payments were for

  • Food & beverage$2,063100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,063 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$125,754
Medicare patients
267
Services billed
1,761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban144$141,985
OzempicSemaglutide124$128,723
TrulicityDulaglutide96$110,154
Trelegy ElliptaFluticasone/Umeclidin/Vilanter118$91,946
JardianceEmpagliflozin31$38,184
XareltoRivaroxaban35$33,287
MounjaroTirzepatide22$26,709
Lantus SolostarInsulin Glargine,hum.Rec.Anlog120$20,992
EntrestoSacubitril/Valsartan18$18,545
Tresiba Flextouch U-200Insulin Degludec21$16,930
Repatha SureclickEvolocumab14$11,204
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,166
MyrbetriqMirabegron21$10,710
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen446$7,967
Atorvastatin Calcium478$7,945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$141,985144 claims
Lilly USA, LLCTrulicity, Mounjaro$74$136,863118 claims
Novo NordiskOzempic$409$128,723124 claims
GSKTrelegy Ellipta, Breo Ellipta$155$98,839133 claims
AstraZenecaBreztri Aerosphere, Brilinta, Farxiga, Symbicort$179$28,77657 claims
MerckJanumet$13$5,94011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Caro

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →